This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration. Need a new registration confirmation email? Click here
07/30/15 - 3:59:53 PM ET (BATS BZX Real-time Price)
Div Yield: --
RVNC Day's Range
RVNC 52 Week Range
RVNC Business Summary
Revance Therapeutics, Inc., a clinical-stage specialty biopharmaceutical company, focuses on the development, manufacture, and commercialization of novel botulinum toxin products for various aesthetic and therapeutic indications.View RVNC key stats
Revance Therapeutics Inc - RVNC - EQUITY
Reviewed By: TheStreet Ratings on .
Report Summary: TheStreet Ratings team rates Revance Therapeutics Inc as a
Hold with a ratings score of C-.
Report Snippet: We rate REVANCE THERAPEUTICS INC (RVNC) a HOLD. The primary factors that have impacted our rating are mixed - some indicating strength, some showing weaknesses, with little evidence to justify the expectation of either a positive or negative performance for this stock relative to most other stocks. The company's strengths can be seen in multiple areas, such as its increase in net income, largely solid financial position with reasonable debt levels by most measures and good cash flow from operations. However, as a counter to these strengths, we find that the growth in the company's earnings per share has not been good.